Market Tracker

02/05 5:16pm ET

TG Therapeutics Inc (NASDAQ:TGTX)

8.50
Delayed Data
As of Feb 05
 -0.10 / -1.16%
Today’s Change
7.32
Today|||52-Week Range
20.00
-28.75%
Year-to-Date
No recent news for TG Therapeutics Inc.

Today’s Trading

Previous close8.60
Today’s open8.50
Day’s range8.32 - 8.93
Volume527,701
Average volume (3 months)588,621
Market cap$446.4M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-102.47%
Earnings growth (this year)+20.37%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales3,541.46
Price/Book4.77

Competitors

 Today’s
change
Today’s
% change
COLLCollegium Pharmaceut...-0.52-2.70%
ACRSAclaris Therapeutics...-0.43-1.96%
XNCRXencor Inc+0.17+1.61%
SCLNSciClone Pharmaceuti...+0.65+8.01%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 2, 2016
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$152.4K
Annual profit (last year)-$55.8M
Net profit margin-36,606.45%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael Sean Weiss
CFO, Secretary, Treasurer &
CAO
Sean A. Power
Corporate headquarters
New York, New York

Forecasts